Immunohistochemical assessment of hepatitis C virus antigen in cholestatic hepatitis after liver transplantation

Journal of Clinical Pathology

Volumn 59, Issue 2, 2006, Pages 174-178

  Fenwick, F ^b   Bassendine, M F ^b   Agarwal, K ^b   Bevitt, D ^b   Pumeechockchai, W ^b   Burt, A D ^b   Toms, G L ^a,b  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORESCEIN; FORMALDEHYDE; GLYCOPROTEIN E1; IMMUNOGLOBULIN G; MONOCLONAL ANTIBODY; MONTIRELIN; PARAFFIN; POLYCLONAL ANTIBODY; VIRUS ANTIGEN;

ANTIGEN DETECTION; ARTICLE; CASE REPORT; CHOLESTATIC HEPATITIS; COMMON VARIABLE IMMUNODEFICIENCY; CONTROLLED STUDY; CYTOPLASM; FEMALE; FROZEN SECTION; GENOME; HEPATITIS C VIRUS; HIGH TEMPERATURE PROCEDURES; HUMAN; HUMAN TISSUE; IMMUNOCOMPETENCE; IMMUNOHISTOCHEMISTRY; LIVER CELL; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; PRIORITY JOURNAL; RECURRENT DISEASE; VIRUS LOAD;

CHOLESTASIS, INTRAHEPATIC; COMMON VARIABLE IMMUNODEFICIENCY; CRYOPRESERVATION; FEMALE; HEPATITIS C; HEPATITIS C ANTIGENS; HEPATOCYTES; HUMANS; LIVER FAILURE; LIVER TRANSPLANTATION; PARAFFIN EMBEDDING; RECURRENCE; VIRAL LOAD;

EID: 32544435495     PISSN: 00219746     EISSN: None     Source Type: Journal    
DOI: 10.1136/jcp.2005.028126     Document Type: Article

References (25)

1. Forman L, Lewis J, Berlin J, et al. The association between hepatitis C infection and survival after orthotopic liver transplantation. Gastroenterology 2002;122:1162-5.
2. Gane E, Naoumov N, Qian K-P, et al. A longitudinal analysis of hepatitis C virus replication following liver transplantation. Gastroenterology 1996;110:167-77.
3. Vargas V, Krawczynski K, Castells L, et al. Recurrent hepatitis C virus infection after liver transplantation: immunohistochemical assessment of the viral antigen. Liver Transpl Surg 1998;4:320-7.
4. Schluger L, Sheiner P, Thung S, et al. Severe recurrent cholestatic hepatitis C following orthotopic liver transplantation. Hepatology 1996;23:971-6.
5. Troppmann C, Rossaro L, Perez R, et al. Early, rapidly progressive cholestatic hepatitis C reinfection and graft loss after adult living donor liver transplantation. Transplantation 2003;3:239-40.
6. Kaneko J, Sugawara Y, Akamatsu N, et al. Cholestatic hepatitis due to hepatitis C virus after a living donor liver transplantation. Hepatogastroenterology 2004;51:243-4.
7. Healey C, Sabharwal N, Daub J, et al. Outbreak of acute hepatitis C following the use of anti-hepatitis C virus-screened intravenous immunoglobulin therapy. Gastroenterology 1996;110:1120-6.
8. Gonzalez S, Talal A. Hepatitis virus in human immunodeficiency virus-infected individuals: an emerging comorbidity with significant implications. Semin Liver Dis 2003;23:149-66.
9. Bjoro K, Schrumpf E, Bergan A, et al. Liver transplantation for endstage hepatitis C cirrhosis in a patient with primary hypogammaglobulinaemia. Scand J Infect Dis 1998;30:520-2.
10. Smith M, Webster A, Dhillon A, et al. Orthotopic liver-transplantation for chronic hepatitis in patients with common variable immunodeficiency. Gastroenterology 1995;108:879-84.
11. Gow P, Mutimer D. Successful outcome of liver transplantation in a patient with hepatitis C and common variable immune deficiency. Transpl Int 2002;15:380-3.
12. McCaughan G, Zekry A. Pathogenesis of hepatitis C virus recurrence in the liver allograft. Liver Transpl 2002;8:S7-13.
13. Ballardini G, Groff P, Giostra F, et al. Hepatocellular codistribution of c100, c33, c22, and NS5 hepatitis C virus antigens detected using immunopurified polyclonal spontaneous human antibodies. Hepatology 1995;21:730-4.
14. Nielsen S, Bassendine M, Burt A, et al. Characterisation of the genome and structural proteins of hepatitis C virus resolved from infected human liver. J Gen Virol 2004;85:1487-507.
15. Pumeechockchai W, Bevitt D, Agarwal K, et al. Hepatitis C virus particles of different density in the blood of chronically infected immunocompetent and immunodeficient patients: implications for virus clearance. J Med Virol 2002;68:335-42.
16. Bevitt DJ, Milton ID, Piggot N, et al. New monoclonal antibodies to oestrogen and progesterone receptors effective for paraffin section immunohistochemistry. J Pathol 1997;183:228-32.
17. Gonzalez-Peralta R, Fang J, Davis G, et al. Optimization for the detection of hepatitis C virus antigens in the liver. J Hepatol 1994;20:143-7.
18. Milton I, Watson J, Guo K, et al. Prokaryotic expression and analysis of the antibody response to a Newcastle isolate of the core gene of hepatitis C. J Med Virol 1995;45:253-8.
19. Brody R, Eng S, Melamed J, et al. Immunohistochemical detection of hepatitis C antigen by monoclonal antibody Tordji-22 compared with PCR viral detection. Am J Clin Pathol 1998;110:32-7.
20. Doughty A, Painter D, McCaughan G. Nonspecificity of monoclonal antibody Tordji-22 for the detection of hepatitis C virus in liver transplant recipients with cholestatic hepatitis. Liver Transpl Surg 1999;5:40-5.
21. Gregorio GV, Pensati P, Iorio R, et al. Autoantibody prevalence in children with liver disease due to chronic hepatitis C virus (HCV) infection. Clin Exp Immunol 1998;112:471-6.
22. Quiroga JA, Pardo M, Navas S, et al. Patterns of immune responses to the host-encoded GOR and hepatitis C virus core-derived epitopes with relation to hepatitis C viremia, genotypes, and liver disease severity. J Infect Dis 1996;173:300-5.
23. Lau J, Krawcynski K, Negro F, et al. In situ detection of hepatitis C virus-a critical appraisal. J Hepatol 1996;24(suppl 2):43-51.
24. Scheuer P, Krawczynski K, Dhillon A. Histopathology and detection of hepatitis C virus in liver. Springer Semin Immunopathol 1997;19:27-45.
25. Ballardini G, Groff P, Pontisso P, et al. Hepatitis C virus (HCV) genotype, tissue HCV antigens, hepatocellular expression of HLA-A,B,C, and intracellular adhesion-molecules. J Clin Invest 1995;95:2067-75.